Literature DB >> 9786612

Increased apolipoprotein E4 allele frequency is associated with vascular dementia in the Hungarian population.

J Kálmán1, A Juhász, A Császár, A Kanka, A Rimanóczy, Z Janka, I Raskó.   

Abstract

INTRODUCTION: The regulatory role of apolipoprotein E in lipid transport and metabolism was utilized to investigate the allelic association between the apolipoprotein E4 (apoE4) allele and vascular dementia (VD) in a selected sample of Hungarian patients with multiple deep subcortical infarcts and leukoaraiosis.
MATERIAL AND METHODS: Thirty-four Caucasian VD cases and 79 healthy control probands were involved in this study according to the criteria of ICD-10 and NINDS-AIREN International Workshop Diagnostic Criteria. The genomic DNA was isolated from whole blood and the apoE alleles were determined by polymerase chain reaction.
RESULTS: The E2, E3 and E4 allele frequencies in the VD group were 5%, 76%, and 19%, respectively; and significant (P<0.03) differences were found in comparison with the data on the healthy controls (E2, 6%; E3, 87%; E4, 8%). The apoE4 allele frequency was intermediate between HC and Alzheimer's dementia group (28%).
CONCLUSION: These results indicate that the apoE4 allele could be a risk factor not only for certain primary degenerative, but also for vascular dementias.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9786612     DOI: 10.1111/j.1600-0404.1998.tb07288.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

1.  ApoE gene polymorphism and vascular dementia in Chinese population: a meta-analysis.

Authors:  Xu Liu; Lei Li; Fang Liu; Shuming Deng; Ruixia Zhu; Qu Li; Zhiyi He
Journal:  J Neural Transm (Vienna)       Date:  2011-10-09       Impact factor: 3.575

Review 2.  Is apolipoprotein E4 an important risk factor for vascular dementia?

Authors:  Troy T Rohn
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia population.

Authors:  Anna Juhász; András Palotás; Zoltán Janka; Agnes Rimanóczy; Miklós Palotás; Nikoletta Bódi; Krisztina Boda; Marianna Zana; Gábor Vincze; János Kálmán
Journal:  Neurochem Res       Date:  2005-05       Impact factor: 3.996

4.  Association between APOE epsilon4 allele and vascular dementia: The Cache County study.

Authors:  Yi-Fang Chuang; Kathleen M Hayden; Maria C Norton; Joann Tschanz; John C S Breitner; Kathleen A Welsh-Bohmer; Peter P Zandi
Journal:  Dement Geriatr Cogn Disord       Date:  2010-04-06       Impact factor: 2.959

5.  Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.

Authors:  Ging-Yuek R Hsiung; A Dessa Sadovnick; Howard Feldman
Journal:  CMAJ       Date:  2004-10-12       Impact factor: 8.262

6.  Apolipoprotein E, angiotensin-converting enzyme and kallikrein gene polymorphisms and the risk of Alzheimer's disease and vascular dementia.

Authors:  H K Wang; H C Fung; W C Hsu; Y R Wu; J C Lin; L S Ro; K H Chang; F J Hwu; Y Hsu; S Y Huang; G J Lee-Chen; C M Chen
Journal:  J Neural Transm (Vienna)       Date:  2006-02-09       Impact factor: 3.575

7.  Candidate-gene analysis of white matter hyperintensities on neuroimaging.

Authors:  Theresa Tran; Ioana Cotlarciuc; Sunaina Yadav; Nazeeha Hasan; Paul Bentley; Christopher Levi; Bradford B Worrall; James F Meschia; Natalia Rost; Pankaj Sharma
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-04-02       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.